Related Experiment Video
Updated: Aug 2, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
Cardiac transplantation: a review for the intensivists
1Division of Cardiovascular Medicine, Stanford University School of Medicine, CA 94305.
Insights
Cardiac transplant recipients require specialized intensive care due to high risks of infection, rejection, and other serious illnesses. Physicians must manage complex cases involving immunosuppression and potential graft complications.
Area of Science:
- Cardiology
- Transplant Surgery
- Critical Care Medicine
Background:
- Cardiac transplantation is a standard treatment for end-stage heart disease in adults and children.
- Thousands of patients worldwide have received cardiac grafts.
- Post-transplant patients face significant risks including infections, graft rejection, cardiac allograft vasculopathy, and malignancy.
Purpose of the Study:
- To highlight the critical role of intensive care unit (ICU) physicians in managing cardiac transplant recipients.
- To underscore the complexities and challenges in providing care for these vulnerable patients.
Main Methods:
- This abstract is a narrative review of the challenges faced by ICU physicians caring for cardiac transplant patients.
- It synthesizes existing knowledge on post-transplant complications and management strategies.
Main Results:
- Cardiac transplant recipients present unique diagnostic and management challenges in the ICU.
- Key concerns include a broad spectrum of infections, frequent drug interactions, and altered immunosuppression levels.
- The possibility of graft rejection remains a significant concern, especially within the first year post-transplant.
Conclusions:
- ICU physicians must be prepared for the demanding care of cardiac transplant patients.
- Comprehensive understanding of post-transplant complications, immunosuppression, and rejection is essential for optimal patient outcomes.
Abstract:
Cardiac transplantation has now become accepted therapy for the treatment of end-stage heart disease in both children and adults, and literally thousands of patients are bearers of cardiac grafts. Because of these patients' susceptibility to infections, rejection, coronary disease, and malignancy, as well as to serious illnesses unrelated to their transplantation, they will often be encountered at hospital centers both close to their homes and distant from the site of their surgery. The intensive care unit physician's role will be a demanding one when caring for these patients because of the broad differential diagnosis of infections, frequency of drug interactions and altered immunosuppression, and continuous uncertainty regarding the possibility of rejection, particularly during the first year after transplantation.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care
Kidney Transplant I: Introduction

